Krka, d. d., Novo mesto - Company Profile and SWOT Analysis
Summary
Krka, d. d., Novo mesto - Company Profile and SWOT Analysis, is a source of comprehensive company data and information. The report covers the company's structure, operation, SWOT analysis, product and service offerings and corporate actions, providing a 360˚ view of the company.
Key Highlights
Krka, d. d., Novo Mesto (Krka or 'the company') is a provider of prescription pharmaceuticals, non-prescription products, and animal health products. Its products are used for the treatment of cardiovascular diseases, diseases of the alimentary tract and metabolism, heart failure, analgesics, cold and cough remedies. The company is also involved in the health resort business, animal health products and provides tourist services. The company markets products under various brands such as atoris, roswera, ampril, lorista, septolete, pikovit, bilobil, flebaven, fypryst, enroxil amatib, otoxolan and flimabend brands, among others. Krka primarily operates in Europe, Africa, the Middle East, and the Americas. The company is headquartered in Novo Mesto, Slovenia.
Scope
Learn how to effectively navigate the market research process to help guide your organization on the journey to success.
Download eBook